BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang LJ, Xue Y, Huo R, Yan Z, Xu H, Li H, Wang J, Zhang Q, Cao Y, Zhao JZ. N6-methyladenosine methyltransferase METTL3 affects the phenotype of cerebral arteriovenous malformation via modulating Notch signaling pathway. J Biomed Sci 2020;27:62. [PMID: 32384926 DOI: 10.1186/s12929-020-00655-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Li M, Zha X, Wang S. The role of N6-methyladenosine mRNA in the tumor microenvironment. Biochim Biophys Acta Rev Cancer 2021;1875:188522. [PMID: 33545295 DOI: 10.1016/j.bbcan.2021.188522] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Wang Y, Xu M, Yue P, Zhang D, Tong J, Li Y. Novel Insights Into the Potential Mechanisms of N6-Methyladenosine RNA Modification on Sepsis-Induced Cardiovascular Dysfunction: An Update Summary on Direct and Indirect Evidences. Front Cell Dev Biol 2021;9:772921. [PMID: 34869371 DOI: 10.3389/fcell.2021.772921] [Reference Citation Analysis]
3 Li B, Zhang T, Liu M, Cui Z, Zhang Y, Liu M, Liu Y, Sun Y, Li M, Tian Y, Yang Y, Jiang H, Liang D. RNA N6-methyladenosine modulates endothelial atherogenic responses to disturbed flow in mice. Elife 2022;11:e69906. [PMID: 35001873 DOI: 10.7554/eLife.69906] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Sikorski V, Karjalainen P, Blokhina D, Oksaharju K, Khan J, Katayama S, Rajala H, Suihko S, Tuohinen S, Teittinen K, Nummi A, Nykänen A, Eskin A, Stark C, Biancari F, Kiss J, Simpanen J, Ropponen J, Lemström K, Savinainen K, Lalowski M, Kaarne M, Jormalainen M, Elomaa O, Koivisto P, Raivio P, Bäckström P, Dahlbacka S, Syrjälä S, Vainikka T, Vähäsilta T, Tuncbag N, Karelson M, Mervaala E, Juvonen T, Laine M, Laurikka J, Vento A, Kankuri E. Epitranscriptomics of Ischemic Heart Disease-The IHD-EPITRAN Study Design and Objectives. Int J Mol Sci 2021;22:6630. [PMID: 34205699 DOI: 10.3390/ijms22126630] [Reference Citation Analysis]
5 Yi D, Wang Q, Zhao Y, Song Y, You H, Wang J, Liu R, Shi Z, Chen X, Luo Q. Alteration of N 6 -Methyladenosine mRNA Methylation in a Rat Model of Cerebral Ischemia-Reperfusion Injury. Front Neurosci 2021;15:605654. [PMID: 33796004 DOI: 10.3389/fnins.2021.605654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lin F, Zeng C, Ge P, Zhang D, Wang S, Zhao J. Prognostic Significance of Homocysteine Level on Neurological Outcome in Brain Arteriovenous Malformations. Dis Markers 2020;2020:6661475. [PMID: 33312268 DOI: 10.1155/2020/6661475] [Reference Citation Analysis]
7 Wang L, Sun X, He J, Liu Z. Functions and Molecular Mechanisms of Deltex Family Ubiquitin E3 Ligases in Development and Disease. Front Cell Dev Biol 2021;9:706997. [PMID: 34513839 DOI: 10.3389/fcell.2021.706997] [Reference Citation Analysis]
8 Chokkalla AK, Mehta SL, Vemuganti R. Epitranscriptomic regulation by m6A RNA methylation in brain development and diseases. J Cereb Blood Flow Metab 2020;40:2331-49. [PMID: 32967524 DOI: 10.1177/0271678X20960033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
9 Jiang W, Zhu P, Huang F, Zhao Z, Zhang T, An X, Liao F, Guo L, Liu Y, Zhou N, Huang X. The RNA Methyltransferase METTL3 Promotes Endothelial Progenitor Cell Angiogenesis in Mandibular Distraction Osteogenesis via the PI3K/AKT Pathway. Front Cell Dev Biol 2021;9:720925. [PMID: 34790657 DOI: 10.3389/fcell.2021.720925] [Reference Citation Analysis]
10 Revici R, Hosseini-alghaderi S, Haslam F, Whiteford R, Baron M. E3 Ubiquitin Ligase Regulators of Notch Receptor Endocytosis: From Flies to Humans. Biomolecules 2022;12:224. [DOI: 10.3390/biom12020224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dong G, Yu J, Shan G, Su L, Yu N, Yang S. N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1. Front Cell Dev Biol 2021;9:731810. [PMID: 34950654 DOI: 10.3389/fcell.2021.731810] [Reference Citation Analysis]
12 Venugopal V, Sumi S. Molecular Biomarkers and Drug Targets in Brain Arteriovenous and Cavernous Malformations: Where Are We? Stroke 2021;:STROKEAHA121035654. [PMID: 34784742 DOI: 10.1161/STROKEAHA.121.035654] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Zhang F, Liu H, Duan M, Wang G, Zhang Z, Wang Y, Qian Y, Yang Z, Jiang X. Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application. J Hematol Oncol 2022;15. [DOI: 10.1186/s13045-022-01304-5] [Reference Citation Analysis]
14 Huang H, Wang X, Guo AN, Li W, Duan RH, Fang JH, Yin B, Li DD. De novo brain arteriovenous malformation formation and development: A case report. World J Clin Cases 2022; 10(18): 6277-6282 [DOI: 10.12998/wjcc.v10.i18.6277] [Reference Citation Analysis]
15 Dutta D, Sharma V, Mutsuddi M, Mukherjee A. Regulation of Notch signaling by E3 ubiquitin ligases. FEBS J 2021. [PMID: 33644958 DOI: 10.1111/febs.15792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Pan P, Weinsheimer S, Cooke D, Winkler E, Abla A, Kim H, Su H. Review of treatment and therapeutic targets in brain arteriovenous malformation. J Cereb Blood Flow Metab 2021;:271678X211026771. [PMID: 34162280 DOI: 10.1177/0271678X211026771] [Reference Citation Analysis]